| Followers | 842 |
| Posts | 122795 |
| Boards Moderated | 10 |
| Alias Born | 09/05/2002 |
Saturday, November 19, 2011 1:51:20 PM
[Updated for SEC filings through 11/14/11.]
The table entries below include both ordinary and restricted
shares and both vested and non-vested options.
*10b5-1 selling plan in effect.
Shares Options
Officers
*Craig Wheeler (CEO) 525,470 752,000
*G Venkataraman (SVP/R&D) 402,403 182,820
*John Bishop (SVP/Pharma) 97,000 125,343
*Richard Shea (CFO) 90,760 272,378
*Bruce Leicher (Gen Cnsl) 90,935 160,228
*James Roach (CMO) 70,194 228,428
Directors
John Clarke 77,123 143,750
Bruce Downey 0 62,750
Marsha Fanucci 0 143,750
Peter Hutt 67,863 148,750
Thomas Koestler 0 30,000
*Bennett Shapiro 7,000 136,950
*Elizabeth Stoner 7,880 76,950
James Sulat 7,000 70,750
======================== ========= =========
All fourteen insiders 1,440,028 2,534,847
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
